Quick View
| Metric | Current Period | Same Period of Previous Year | YoY |
|---|---|---|---|
| Revenue | ¥17063.3B | ¥19048.3B | −10.4% |
| Operating Income | ¥1804.2B | ¥1454.3B | +24.1% |
| Profit Before Tax | ¥1444.0B | ¥400.7B | +260.4% |
| Net Income | ¥1441.5B | ¥406.9B | +254.2% |
| ROE (Annualized) | 15.2% | 5.1% | - |
Executive Summary
While revenue declined 10.4%, operating income and net income increased substantially, resulting in earnings growth driven by profitability. Revenue was ¥17063.3B (-10.4% YoY), operating income was ¥1804.2B (+24.1% YoY), profit before tax, equivalent to ordinary income, was ¥1444.0B, and consolidated net income was ¥1441.5B (+254.2% YoY), compared with slightly less than ¥874B in net income attributable to owners of the parent. The primary drivers of earnings growth were an improvement in gross margin resulting from a lower cost ratio (31.0%, up +2.8pt from 28.2% in the previous year) and a turnaround to a ¥432.1B profit in share of profit of investments accounted for using the equity method.
Factors Driving Earnings Changes
【Revenue】Revenue was ¥17063.3B, down 10.4% year on year. The primary factor behind the decline in revenue appears to have been deteriorating market conditions due to volume and price factors, reflecting the demand cycle in the Chemicals Business.
【Profit and Loss】Operating income was ¥1804.2B (+24.1% YoY), and the operating margin expanded to 10.6% from 7.6% in the previous year, an increase of 2.9pt. The improvement in gross margin to 31.0% (28.2% in the previous year), together with a 6.6% decrease in SG&A expenses to ¥4166.8B, drove earnings growth. However, the SG&A ratio increased year on year to 24.4%, indicating continued challenges in absorbing fixed costs amid declining revenue. Financial expenses of ¥484.1B exceeded financial income of ¥124.0B, resulting in a net burden of ¥360.1B; however, equity-method gains and losses swung from a loss in the previous year by ¥432.1B, enabling the Company to secure profit before tax of ¥1444.0B and net income of ¥1441.5B (+254.2% YoY). In conclusion, the current results represent declining revenue but higher earnings.
Key Financial Indicators
【Profitability】The operating margin of 10.6% improved by 2.9pt from 7.6% in the same period of the previous year, while the gross margin also expanded to 31.0% from 28.2%. ROE (annualized) was 15.2%.【Cash Flow Quality】Operating Cash Flow (OCF) was ¥1116.1B, down 20.7% year on year, but free cash flow remained positive at ¥717.7B. The expansion in working capital, including a ¥332.0B increase in inventories, placed pressure on OCF and warrants attention when assessing earnings quality.【Investment Efficiency】Share of profit of investments accounted for using the equity method was ¥432.1B, making a significant contribution to net income; fluctuations in the performance of investee companies therefore have a substantial impact on consolidated earnings.【Financial Soundness】The equity ratio improved to 29.3% from 26.2% in the previous year, an improvement of 3.1pt, strengthening the financial foundation. Total bonds and borrowings were ¥12214.8B, and interest-bearing debt service capacity, as viewed through the ratio of financial expenses to EBIT, remains subject to monitoring.
Cash Flow Analysis
Although OCF declined 20.7% year on year to ¥1116.1B, the Company maintained sufficient cash-generation capacity relative to net income. A ¥332.0B increase in inventories and a ¥49.8B decrease in trade payables placed pressure on working capital and were factors reducing OCF from subtotal operating cash flow of ¥1460.5B. Investing Cash Flow was an outflow of ¥398.4B, resulting in positive free cash flow of ¥717.7B. Financing Cash Flow was an outflow of ¥1005.7B, with repayment of long-term borrowings and dividend payments of ¥196.7B being the primary uses of funds. Cash and cash equivalents amounted to ¥2147.7B, including foreign currency translation differences of ¥115.0B, representing a slight decrease from the previous year.
Earnings Quality
The improvement in earnings for the current period includes not only recurring factors such as a lower cost ratio, but also a component dependent on the performance of investee companies, namely share of profit of investments accounted for using the equity method of ¥432.1B. Financial expenses of ¥484.1B were recorded against financial income of ¥124.0B, resulting in a net financial burden of ¥360.1B. The fact that OCF has been trending below net income reflects an expansion in working capital, including increases in inventories and trade receivables; from an accrual perspective, the cash backing of earnings warrants somewhat cautious verification. Assessing the earnings power of the core businesses excluding equity-method gains and fluctuations in temporary financial gains and losses will be important in evaluating future earnings levels.
Earnings Forecast and Guidance
The full-year Company forecast is revenue of ¥23000.0B and operating income of ¥1650.0B (-14.5% YoY). While the Q3 cumulative revenue progress ratio is 74.2%, a standard level, cumulative operating income has already exceeded the full-year forecast at ¥1804.2B, representing a progress ratio of 109.3%. Full-year forecast EPS is ¥33.61, while cumulative Q3 basic EPS is ¥53.38, exceeding the forecast. This progress suggests that the full-year plan is conservative and incorporates the possibility of a reversal in the benefits from equity-method gains and gross-margin improvement. Performance in Q4 will therefore be the focus in assessing achievement of the plan.
Shareholder Returns
The Q2 dividend was ¥6.0 per share, while the full-year forecast dividend is ¥13.5. Total dividend payments were ¥196.7B, and virtually no share buybacks were conducted (¥0.0B); accordingly, the difference between the payout ratio and total return ratio is limited. Dividend payments are sufficiently covered by free cash flow of ¥717.7B, leaving ample funding capacity for dividends as of the cumulative Q3 period.
Risk Factors
-
Working Capital Efficiency Risk: Inventories increased 5.8% year on year to ¥6614.0B. The buildup of inventory amid a 10.4% decline in revenue increases the risk of funds being tied up and inventory valuation losses.
-
Financial Expense and Interest Burden Risk: Total borrowings reached ¥12214.8B, while financial expenses of ¥484.1B substantially exceeded financial income of ¥124.0B. The burden of financial expenses relative to operating income requires ongoing monitoring.
-
Performance Volatility Risk of Equity-Method Investee Companies: Share of profit of investments accounted for using the equity method of ¥432.1B represents approximately 30% of net income, creating a structure in which changes in market conditions and overseas operating environments at investee companies can significantly affect consolidated earnings.
Industry Benchmark (Reference; Based on Our Analysis)
Industry Benchmark (manufacturing)
Profitability and Returns
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Operating Margin | 10.6% | 8.6% (4.3%–12.7%) | +2.0pt |
| Net Profit Margin | 8.4% | 6.4% (2.8%–10.3%) | +2.0pt |
Both the operating margin and net profit margin exceed the industry median, indicating that profitability is relatively strong within the industry.
Growth and Capital Efficiency
| Metric | Company | Median (IQR) | Delta |
|---|---|---|---|
| Revenue Growth Rate (YoY) | −10.4% | 3.3% (-2.1%–8.9%) | −13.7pt |
The revenue growth rate is substantially below the industry median, and the contraction in the top line is a particularly notable characteristic within the industry.
※Source: Based on our analysis
Key Points from the Financial Results
-
Despite declining revenue, the operating margin improved by 2.9pt, making the strengthening of profitability centered on a lower cost ratio a key characteristic of the current results.
-
The expansion in working capital, centered on the increase in inventories, placed pressure on OCF. The balance between earnings improvement and cash generation will be a key point for future review.
-
Cumulative Q3 operating income and net income have already made substantial progress against the full-year forecast. Q4 results will therefore be closely watched to validate the assumptions underlying the Company’s plan.
Theoretical Share Price (Reference Value)
| Scenario | Theoretical Share Price |
|---|---|
| bear (bearish) | ¥559 |
| base (base case) | ¥570 |
| bull (bullish) | ¥574 |
| Calculation Assumption | Value |
|---|---|
| Book Value per Share (BPS) | ¥629 |
| Adjusted Forecast EPS | ¥37.0 |
| Cost of Equity r | 9.27% (10-year Japanese government bond 2.77% + equity risk premium 6.00% + size premium 0.50%) |
| Persistence Coefficient of Residual Income ω / Explicit Forecast Period | 0.62 / 5 years |
| Assumed Payout Ratio | 40.2% |
| Forecast EPS Confidence Adjustment | ×1.100 (based on progress ahead of the full-year forecast) |
| Implied PBR / PER | 0.91x / 15.4x |
Sensitivity: ¥554–¥586 at ±1% cost of equity, and ¥568–¥571 at ω±0.1.
Notes:
- Since net income progress against the full-year forecast (159%) exceeds the standard level (75%), forecast EPS has been adjusted upward within a range of +10% at the upper limit (because companies whose progress is ahead of schedule tend to exceed forecasts. For businesses with strong seasonality, the adjustment may be excessive).
- Net income is substantially compressed relative to operating income due to tax burden, acquisition-related expenses, and non-controlling interests, among other factors (net income ÷ operating income 33%). This figure reflects that compression at face value; if the factors are temporary, the underlying earnings power may be higher.
- Since forecast ROE is below the cost of equity, the theoretical value is below book value per share.
- Net assets as of the end of the quarter are used (there is a timing difference from the full-year forecast).
(Calculation model: Residual Income Model (Ohlson-type; explicit 5-year fade) / Interest Rate Base Month: 2026-07 / Mechanically calculated value based solely on publicly disclosed data; this is not a forecast of the market share price or a recommendation of any specific investment action, and does not predict or guarantee future share prices)
This report is an earnings analysis document automatically generated by AI based on XBRL earnings summary data. It does not recommend investment in any specific security. The industry benchmarks are reference information compiled by our company based on publicly disclosed earnings data. Investment decisions should be made at your own discretion and responsibility, after consulting with professionals as necessary.
---End of Report---